| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3721 |
| Trial ID | NCT06210243 |
| Disease | B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | C752 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Single-arm, Open-label Clinical Study to Assess the Safety and Efficacy of the C752 CAR-T Cells for Patients With CD19+ Refractory/Relapsed B Cell Non-Hodgkin Lymphoma |
| Year | 2023 |
| Country | China |
| Company sponsor | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China |
| Other ID(s) | PH02001 |
| Cohort 1 | |||||||
|
|||||||